Medx Health Corp V.MDX

Alternate Symbol(s): MDXHF

Healthcare Medical Devices

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.

TSXV:MDX - Post by User

Medx Health Corp > Interesting, PP at 18 cents just announced

<< Previous

Bullboard Posts

Next >>

Comment by Infidel_on Jun 01, 2021 1:19pm

108 Views

Post# 33303838

RE:RE:RE:RE:RE:Interesting, PP at 18 cents just announced

Infidel_ wrote:

Insightful1 wrote: MedX like any company looks at opportunities and the costy of opportunities. If a strategic investor wants to put capital into MedX's tresury and that enhance MedX's balance sheet and opens up opportunities to MedX you take the money. You only do this if it speeds up your time to market. I take it that is what is behind this PP. It was done a a premium to the market which is a very good sign.

You have to stop looking at dilution as your benchmark look at the market capitalization as the benchmark it is the more relevant number. MedX could do a 20 to 1 roll-bact and that would solve the shares outstanding issue and I would highly recommend they do that once they have established a meaningful revenue base. MedX is driving to be cash flow positivethis year which is different then debt free as I am sure you are well aware.

foreshadowing.

first off, we are all investors. we own stock at a certain price. that means it is the STOCK PRICE, not the market cap that matters to us. So yes dilution matters because it means existing holders get boned. again.

and you do realize that just because you print and sell a bunch more shares (ie dilution) it doesn't automatically add to the market cap right? unless the company uses the money to improve, grow, expand, innovate (or you know do all those things you have been saying are coming around the next corner) the share price gets adjusted accordingly and the mc stays the same or drops. and these financing terms smack of total desperation. of course it was done at a "premium" when you toss it all those goodies. every broker around would take those terms and sell this to their clients who eat all the risk. a good sign? don't insult us.

and hey, what strategic investor was this financing done for? didn't see that in the news release which seems odd.

this is such a clown show.